Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
254.13
+4.28 (1.71%)
Aug 7, 2026, 2:27 PM EDT - Market open
Ascendis Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $345 | Buy | Maintains | $345 | +35.76% | Aug 7, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $329 | Buy | Maintains | $329 | +29.46% | Aug 7, 2026 |
| Wedbush | Wedbush | Buy Maintains $327 | Buy | Maintains | $327 | +28.68% | Aug 6, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $275 | Buy | Reiterates | $275 | +8.21% | Aug 3, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $260 → $300 | Buy | Maintains | $260 → $300 | +18.05% | Jul 27, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $288 → $306 | Buy | Reiterates | $288 → $306 | +20.41% | Jul 14, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $275 → $280 | Buy | Maintains | $275 → $280 | +10.18% | Jul 7, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 18, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.